Premium
Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12‐lipoxygenase
Author(s) -
McCabe N. Patrick,
Selman Steven H.,
Jankun Jerzy
Publication year - 2006
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20360
Subject(s) - angiogenesis , pertussis toxin , cancer research , vascular endothelial growth factor , prostate cancer , cancer cell , endocrinology , growth factor , biology , signal transduction , medicine , receptor , cancer , microbiology and biotechnology , g protein , vegf receptors
BACKGROUND Elevated platelet 12‐Lipoxygenase (P12‐LOX) expression is associated with advanced stage and grade prostate cancer and overexpression in PC‐3 cells promotes tumor growth and angiogenesis. The mechanisms underlying the role of P12‐LOX in angiogenesis remain unclear. METHODS Enzyme linked immunosorbent assays were used to measure 12(S)‐hydroxyeicosatetraenoic acid (12(S)‐HETE) and vascular endothelial growth factor (VEGF) in conditioned media of PC‐3 cells stably overexpressing human P12‐LOX. Immunoblotting was used to observe stimulation of signal transduction in prostate cancer cell lines following exposure to 12(S)‐HETE. RESULTS P12‐LOX overexpression promotes increased accumulation of 12(S)‐HETE and VEGF in culture media leading to constitutive ERK1/2 phosphorylation. 12(S)‐HETE stimulates ERK1/2 phosphorylation via a pertussis toxin sensitive G‐protein coupled receptor (GPCR) and MEK; the inhibition of which reduces VEGF accumulation by 36% and 70%, respectively. CONCLUSIONS Our data provide insight into a possible mechanism by which prostate cancer cells with elevated expression of P12‐LOX stimulate VEGF production, thus increasing their angiogenic potential. Prostate © 2006 Wiley‐Liss, Inc.